The aforementioned results demonstrated that the ZIKV envelope protein is palmitoylated by ZDHHC11, and treatment with the palmitoylation inhibitor, 2-BP, promotes ZIKV infection. This evidence concerns the gene ZDHHC11 and Zika virus infectious disease.